Take Solutions Ltd - Stock Valuation and Financial Performance

BSE: 532890 | NSE: TAKE | IT - Software | Small Cap

Take Solutions Share Price

20.70 -0.86 -3.99%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Take Solutions

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Fair

3. Price Trend

Take Solutions stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
319 Cr.
52-wk low:
12.7
52-wk high:
35.8

Is Take Solutions Ltd an attractive stock to invest in?

1. Is Take Solutions Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Take Solutions Ltd is a below average quality company.

2. Is Take Solutions Ltd undervalued or overvalued?

The key valuation ratios of Take Solutions Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Take Solutions Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Take Solutions Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Take Solutions:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Take Solutions Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 5.9%1.9%2.5%1.1%0.9%0.9%0.4%-0.4%-1.4%1.5%-
Value Creation
Index
-0.6-0.9-0.8-0.9-0.9-0.9-1.0-1.0-1.1-0.9-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 2625.923.618.82.4222.5121856.220
Sales YoY Gr.--0.5%-9%-20.1%-87.1%800%-88.8%387%49.6%212.4%-
Adj EPS 1.40.50.70.20.30.50.2-0.2-0.50.3-0.1
YoY Gr.--64.3%37.3%-67.1%43.5%36.4%-62.2%-235.3%NANA-
BVPS (₹) 26.726.426.538.351.550.95151.719.520.420.1
Adj Net
Profit
17.16.18.434.86.72.5-3.4-7.74.2-2
Cash Flow from Ops. 0-2.6-10.8-33-2412.9-14.9-2.732.626.9-
Debt/CF from Ops. 00-6.80000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 8.9%87.3%183.4%212.4%
Adj EPS -16.6%-3.2%18.1%NA
BVPS-3%-16.9%-26.4%4.7%
Share Price -4.4% -32.1% -23.8% 60.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
5.41.92.60.70.80.90.3-0.4-1.41.4-0.5
Op. Profit
Mgn %
13.85.622.1-16.7-664.4-63.2-685.8-25.8-74.25.118.4
Net Profit
Mgn %
65.823.435.616.2197.230.3101.7-28.2-42.67.4-8.1
Debt to
Equity
000.20000000-
Working Cap
Days
8226257891,93626,1203,64235,7317,5993,69458590
Cash Conv.
Cycle
-29-179-130-172723497975-79-31467

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 183.42%

Return on Equity is Poor

Sales growth is not so good in last 4 quarters at -48.29%

Latest Financials - Take Solutions Ltd.

Standalone Consolidated
TTM EPS (₹) -0.1 -4.4
TTM Sales (₹ Cr.) 20.2 89.9
BVPS (₹.) 20.1 6.8
Reserves (₹ Cr.) 282 85
P/BV 1.07 3.19
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 12.70 / 35.78
All Time Low / High (₹) 4.70 / 308.30
Market Cap (₹ Cr.) 319
Equity (₹ Cr.) 14.8
Face Value (₹) 1
Industry PE 33.5

Management X-Ray of Take Solutions:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Take Solutions

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales262624192222121856
Operating Expenses 22241823193619193153
Manufacturing Costs0000111011
Material Costs0000000000
Employee Cost 6236576443
Other Costs 16221617132812142650
Operating Profit 415-4-16-14-17-7-133
Operating Profit Margin (%) 13.8%5.6%22.1%-20.8%-664.0%-63.2%-685.0%-57.1%-74.2%5.1%
Other Income 221316223334261179
Interest 2003100001
Depreciation 5101112211
Exceptional Items 00000000-5-5
Profit Before Tax 1813201515207-7-35
Tax 1220-12-1-120
Profit After Tax 1711181415178-6-54
PAT Margin (%) 65.8%43.7%77.3%76.5%625.6%79.2%313.7%-50.1%-28.4%7.6%
Adjusted EPS (₹)1.40.91.51.11.01.20.5-0.4-0.40.3
Dividend Payout Ratio (%)70%106%66%92%155%85%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 320316319511762753755764288301
Share Capital 12121213151515151515
Reserves 308304307497747738740750273286
Minority Interest0000000000
Debt00730000000
Long Term Debt0000000000
Short Term Debt00730000000
Trade Payables4241101245
Others Liabilities 1071821121919181912
Total Liabilities 333325414533775773774784312318

Fixed Assets

Gross Block2434255510101010
Accumulated Depreciation042421224678
Net Fixed Assets2105436432
CWIP 0020000000
Investments 284234330360414512517517155243
Inventories0000000000
Trade Receivables3343167240
Cash Equivalents 44424251522511237
Others Assets40435214020422724324914767
Total Assets 333325414533775773774784312318

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 0-3-11-33-2413-15-33327
PBT 0132015152077-4745
Adjustment 0-5-63-3-18-12-19468-1
Changes in Working Capital 0-8-22-46-3312-8104028
Tax Paid 0-2-2-5-3-1-100-4
Cash Flow From Investing Activity 055-92-24-88-1122213-40-22
Capex 00-2-30001700
Net Investments 050-91-25-50-93230030
Others 0524-38-19-1-4-40-52
Cash Flow From Financing Activity 0-126158239-28-80-1-1
Net Proceeds from Shares 00017325000000
Net Proceeds from Borrowing 0000000000
Interest Paid 000-3-100000
Dividend Paid 0-12-12-13-13-28-7000
Others 0073-9940-10-1-1
Net Cash Flow 041-421127-127-111-94
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)5.373.565.743.482.42.31.03-0.79-0.971.46
ROCE (%)6.364.245.843.882.462.570.97-0.9-0.461.79
Asset Turnover Ratio0.080.080.060.0400.0300.020.030.18
PAT to CFO Conversion(x)0-0.27-0.61-2.36-1.60.76-1.88N/AN/A6.75
Working Capital Days
Receivable Days6440526730661994142680
Inventory Days00111624000
Payable Days0000000000

Take Solutions Ltd Stock News

Take Solutions Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Take Solutions on 28-Mar-2024 16:01 is ₹20.70.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Take Solutions stood at ₹318.9.
The latest P/E ratio of Take Solutions as of 28-Mar-2024 16:01 is 0.00.
The latest P/B ratio of Take Solutions as of 28-Mar-2024 16:01 is 1.07.
The 52-week high of Take Solutions is ₹35.78 and the 52-week low is ₹12.70.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Take Solutions is ₹20.21 ( Cr.) .

About Take Solutions Ltd

TAKE Solutions is a globally-recognized domain-leader in Life Sciences and Supply Chain Management. TAKE leverages its domain expertise, innovation-driven technology, best practices and people strength to offer clients transformative full services across clinical development, and point services in supply chain. In the fast-growing Life Sciences space, TAKE offers clients a unique combination of full-service Clinical, Regulatory and Safety services backed by unique technology expertise. Its range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry networks forums.

With a team of leading Life Sciences experts, best-in-class systems and processes, and bespoke, industry-specific technology and analytics, TAKE delivers successful outcomes for clients. Its global roster of clients includes large and small innovator biopharmaceutical companies as well as generics manufacturers. In Supply Chain Management, TAKE focuses on high-margin niches in engineering services, and supply chain collaboration. Its IP-led approach enables its clients to automate supply chain processes, track, trace & control at item level, mandate supplier compliance, and streamline material & shipment movement, and thus optimize their processes. With operations spread across North America, Europe, Asia, and South America, TAKE is a Public Company, listed in India on the Bombay Stock Exchange and the National Stock Exchange.

Business area of the company

The company delivers domain-intensive services in Life Sciences and Supply Chain Management. The company offers clients a unique combination of full service Clinical, Regulatory and Safety services with unique technology expertise. The Company's services span clinical trials to regulatory submissions to post-marketing strategy with insights derived through proprietary industry network forums.

Products and services

Life Sciences:

  • Life sciences home: implementation of clinical data standards for sponsor process enhancement and preparation of compliant clinical data. Services focused on leveraging the standardization process into Clinical Study and Summary (ISS/ISE) reports.
  • Clinical data offerings: SDTM consultation and Full clinical data lifecycle services, from CRF design to ISS/ISE.
  • Regulatory offerings: PharmaReady, an exclusive brand of TAKE Solutions, is a fully integrated web-based eDMS and eCTD Submissions Solution Suite.
  • Drug safety offerings: Complete Pharmacovigilance Safety System and Clinical Trials Safety Surveillance.

Supply Chain Management:

  • Demand Driven Supply Network
  • Demand Driven Distribution & Fulfillment
  • Mobile Applications & Auto-ID
  • Global Trade Management

Company’s technology products and solutions are:

  • Business Process Management Solutions- TAKE RTE (real time enterprise)
  • TAKE BI Solutions, the Business Intelligence practice of TAKE Solutions, delivers custom solutions that enable companies to tap the full potential of their business capabilities by helping them access, analyze and share information anytime and anywhere.
  • Microsoft solutions
  • Enterprise desktop management solutions

Awards

  • 2008: Recognized by Deloitte as India’s 10th fastest growing technology company
  • 2009: Listed in Food Logistics magazine’s FL 100+ Software & Technology Providers list for third consecutive year
  • 2010: Received MMA (Madras Management Association) award for Managerial Excellence 2010 in the Services category
  • 2010: Recognized by Supply Chain Brain as a Great Supply Chain Partner 2010 for fourth consecutive year
  • 2012: Recognized for “Significant Contribution to SCM field” at Spectrum Confluence 2012 organized by Indian Institute of Materials Management (IIMM) Chennai
  • 2012: Listed on the 2012 Supply and Demand Chain Executive 100 List for the second consecutive year
  • 2012: Recognized as TOP 100 Logistics IT Providers by Inbound Logistics magazine
  • 2013: Emerged as Asia’s Second Best Employer Brand. Declared as Best among 30 Companies from across 33 countries in Singapore
  • 2013: Recognized by Supply Chain Brain’s “2012 Great Supply Chain Partner” list
  • 2013: Named in Software Magazine’s 30th Annual Software 500 as one of the world’s largest software and service companies
  • 2013: Ranked by Inc. India magazine as one of India’s fastest growing top 500 mid-size companies
  • 2014: Won the Best Employer Brand Award at the World HRD Congress, with a total of 14 award wins
  • 2014: Named in 2013 Supply and Demand Chain Executive 100
  • 2014: Listed in Software Magazine’s 31st ‘Annual Software 500’ ranking for the second consecutive year
  • 2015: Ranked 2nd as the Dream Employer of Year, in Technology, at the World HRD Congress, with a total of 16 award wins
  • 2015: Named in Software Magazine’s 32nd Annual Software 500 ranking of the world’s largest software and service providers for the third consecutive year
  • 2016: Received a Special Commendation for Excellence in Corporate Governance at the Golden Peacock Awards
  • 2016: Declared ‘HR Company of the Year’ from amongst over 400 companies at the World HRD Congress
  • 2016: Adjudged the ‘Most Admired Brand – IT’ at the 5th Asian Customer Engagement Forum Awards that recognize excellence in Branding, Marketing and CSR
  • 2017: Received the Golden Peacock Award for Excellence in Corporate Governance
  • 2017: Chosen as one of the ‘Great Places to Work’ for its exemplary workplace culture
  • 2017: Awarded Silver recognition level by EcoVadis for Sustainability & CSR Performance
  • 2017: Received awards for the ‘Most Effective Campaign’, “Best use of video content’ and ‘Best Media Relations/PR at the prestigious Asian Customer Engagement Forum Awards
  • 2017: Received titles of ‘Dream Company to Work For’ and ‘Best Employer Brand’, and 27 other titles at the World HRD Congress
  • 2018: Won the award for Best Employer Brand for the 2nd consecutive year at the World HRD Congress 2018, and ranked 3rd in the Times Ascent presents Dream Companies to Work For category
  • 2018: Earned a place in the Great Place to Work global listing, the global authority on building, sustaining & recognizing exemplary workplace culture and best practices
  • 2018: Bestowed with the Golden Peacock Award for Excellence in Corporate Governance, for the 2nd consecutive year in 2018
  • 2019: Awarded Silver recognition level by EcoVadis for Sustainability & CSR Performance
  • 2020: CEO Insights Top 10 Clinical Trials Service Providers - 2020

Milestones

2000-2004

  • Inaugurated North American headquarters at Princeton, New Jersey, USA
  • TAKE Solutions was founded in Chennai, India

2007-2010

  • Inaugurated a state-of-the-art global delivery center in Chennai, India
  • Acquired OnSphere Corporation, Raleigh, North Carolina, USA, an IP-driven leader in regulatory compliance for Life Sciences
  • Launched OneSCM, a multi-tenant SaaS platform to improve enterprise supplier management
  • Acquired ClearOrbit, a Supply Chain Management software company in Austin, Texas, USA
  • Registered a successful IPO and listed on the Bombay Stock Exchange and the National Stock Exchange in India.

2011-2014

  • Recognized as a leader in IDC MarketScape on Drug Safety Services Worldwide Life Science Drug Safety Services 2013 Vendor Assessment
  • Acquired UK-based WCI Consulting Group, a leading patient safety and compliance advisor to the Life Sciences industry
  • Launched SafetyReady to increase the efficiency of Oracle Argus Safety Suite for Life Sciences
  • Recognized as a Leader in IDC MarketScape: Worldwide Life Sciences R&D IT Outsourcing 2011

2015

  • Launched cdsnet, a proprietary industry network on Clinical Data Strategy
  • Launched Latin American Regulatory Operations Hub in Bogota, Columbia
  • Awarded patent by the United States Patent and Trademark Office (USPTO) for “Method for Optimizing Clinical Data Standardization”
  • Launched India’s first propriety industry network on pharmacovigilance, pvindia
  • Launched pharmaReady 6.0, an update to proprietary web-based electronic document management and eSubmission solution for Life Sciences

2016

  • Acquired Ecron Acunova, a full-service CRO with Clinical & BA/BE capabilities
  • 100th pharmaReady customer win

2017

  • Navitas Life Sciences named as a Leader in IDC MarketScape: Worldwide Life Science Drug Safety Services 2017 Vendor Assessment
  • Consolidated Life Sciences businesses under the brand Navitas Life Sciences to provide full services across Clinical, Regulatory and Safety
  • Launched Labeling Assessment Express to improve End-to-End labeling for Life Sciences
  • Celebrated the landmark 15th year of its proprietary Life Sciences industry network forums
  • Updated and significantly expanded OneSCM Supply Chain Collaboration Suite
  • Launched the Gemini Series Android App for Smartphones

2018

  • Inaugurated satellite hub in Chennai to deliver end-to-end dossier submission for APAC region for one of the largest global pharma companies
  • Navitas Life Sciences recognized as ‘Leader’ in the IDC MarketScape: Drug Safety Services 2018 Vendor Assessment as one of only 8 vendors selected based on stringent research and due diligence
  • Expanded operations in Colombia to offer full-service clinical, regulatory and pharmacovigilance/safety and technology offerings across Latin America
  • Gartner recognized the Company amongst Top 20 Global Solution Providers in its Market Guide for Track-and-Trace and Serialization Software Providers for Life Sciences Companies
  • TAKE recognised in CIO Review’s ‘20 Most Promising Pharma and Life Sciences Tech Companies'
  • Inaugurated state-of-the-art Clinical facility in Chennai to conduct Bioavailability & Bioequivalence studies

2019-20

  • Everest Group's Life Sciences Clinical Trials Products PEAK Matrix Assessment 2019 recognized Navitas Life Sciences as a Major Contender
  • Acquired US-based, full-service contract research organization (CRO) and health-research company KAI Research
  • Acquired DataCeutics, an American Clinical Data Sciences services company that provides quality SAS based statistical programming, clinical reporting and clinical data management
  • 175+ customers for pharmaREADY, its cloud-based Regulatory Submissions management platform
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.